Format
Items per page
Sort by

Send to:

Choose Destination

Results: 10

Related Articles by Review for PubMed (Select 22439933)

1.

Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.

Zhu S, Lee JS, Guo F, Shin J, Perez-Atayde AR, Kutok JL, Rodig SJ, Neuberg DS, Helman D, Feng H, Stewart RA, Wang W, George RE, Kanki JP, Look AT.

Cancer Cell. 2012 Mar 20;21(3):362-73. doi: 10.1016/j.ccr.2012.02.010.

2.

New strategies in neuroblastoma: Therapeutic targeting of MYCN and ALK.

Barone G, Anderson J, Pearson AD, Petrie K, Chesler L.

Clin Cancer Res. 2013 Nov 1;19(21):5814-21. doi: 10.1158/1078-0432.CCR-13-0680. Epub 2013 Aug 21. Review.

3.

New insights into the genetics of neuroblastoma.

Sridhar S, Al-Moallem B, Kamal H, Terrile M, Stallings RL.

Mol Diagn Ther. 2013 Apr;17(2):63-9. doi: 10.1007/s40291-013-0019-6. Review.

PMID:
23329364
4.

MDM2 as MYCN transcriptional target: implications for neuroblastoma pathogenesis.

Slack A, Lozano G, Shohet JM.

Cancer Lett. 2005 Oct 18;228(1-2):21-7. Review.

PMID:
15927364
5.

The MYCN oncogene and differentiation in neuroblastoma.

Westermark UK, Wilhelm M, Frenzel A, Henriksson MA.

Semin Cancer Biol. 2011 Oct;21(4):256-66. doi: 10.1016/j.semcancer.2011.08.001. Epub 2011 Aug 9. Review.

PMID:
21849159
6.

The MYCN oncoprotein as a drug development target.

Lu X, Pearson A, Lunec J.

Cancer Lett. 2003 Jul 18;197(1-2):125-30. Review.

PMID:
12880971
7.

Emerging importance of ALK in neuroblastoma.

Azarova AM, Gautam G, George RE.

Semin Cancer Biol. 2011 Oct;21(4):267-75. doi: 10.1016/j.semcancer.2011.09.005. Epub 2011 Sep 16. Review.

8.

Neuroblastoma models for insights into tumorigenesis and new therapies.

Kiyonari S, Kadomatsu K.

Expert Opin Drug Discov. 2015 Jan;10(1):53-62. doi: 10.1517/17460441.2015.974544. Epub 2014 Oct 25. Review.

PMID:
25345447
9.

Neuroblastoma: developmental biology, cancer genomics and immunotherapy.

Cheung NK, Dyer MA.

Nat Rev Cancer. 2013 Jun;13(6):397-411. doi: 10.1038/nrc3526. Review.

10.

Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.

Chesler L, Weiss WA.

Semin Cancer Biol. 2011 Oct;21(4):245-55. doi: 10.1016/j.semcancer.2011.09.011. Epub 2011 Sep 21. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk